INDICATION: QUZYTTIR is
indicated for the treatment of acute urticaria in adults and
children 6 months of age and older.
- On this page:
- Reimbursement resources
- Co-pay
INDICATION: QUZYTTIR is
indicated for the treatment of acute urticaria in adults and
children 6 months of age and older.
Actor portrayals.
TerSera SupportSource offers:
Call TerSera SupportSource at
1-855-686-8725
Monday-Friday, 9:00 AM – 6:00
PM EST
Request samples through the QUZYTTIR Sample Program to evaluate whether QUZYTTIR may be right for your appropriate patients.
Contact your QUZYTTIR Account Manager to request samples.
The QUZYTTIR Assurance Program helps address reimbursement concerns by providing a credit for your practice if your patient's qualified claim is denied.
Contact TerSera SupportSource to learn more.
Access the full Reimbursement Guide for help with billing, coding, ordering, and more.
Disclaimer
Third-party reimbursement is affected by many factors. The information and assistance provided by TerSera SupportSource are presented for informational purposes only. They do not constitute reimbursement or legal advice. TerSera SupportSource does not promise or guarantee coverage, levels of reimbursement, or payment. Similarly, all Current Procedural Terminology (CPT) and Healthcare Common Procedure Coding System (HCPCS) codes are supplied for informational purposes only and represent no statement, promise, or guarantee, expressed or implied, by TerSera or its third-party service providers that these codes will be appropriate or that reimbursement will be made. The fact that a drug, device, procedure, or service is assigned an HCPCS code and a payment rate does not imply coverage by the Medicare program, but indicates only how the product, procedure, or service may be paid if covered by the Medicare program. Laws, regulations, and policies concerning reimbursement are complex and are updated frequently. Accordingly, the information may not be current or comprehensive. TerSera and its third-party service providers strongly recommend you consult your payer for its most current coverage, reimbursement, and coding policies. TerSera and its third-party service providers make no representations or warranties, expressed or implied, as to the accuracy of the information provided. In no event shall the third-party service providers or TerSera, or their employees or agents, be liable for any damages resulting from or relating to any information provided by, or accessed to or through, TerSera SupportSource. All HCPs and other users of this information agree that they accept responsibility for the use of this program.
Eligible, commercially insured patients may pay as little as $0 co-pay.*
Get more information about QUZYTTIR and resources available to support your patients.